Skip to main content
logo
BioStem Technologies, Inc. (BSEM)
OTCMKTS · Delayed Price · Currency is USD
4.550
-0.130 (-2.78%)
Apr 16, 2026, 2:33 PM EST

BioStem Technologies Revenue

In the year 2025, BioStem Technologies had annual revenue of $47.48M, down -84.27%. BioStem Technologies had revenue of $10.08M in the quarter ending December 31, 2025, a decrease of -90.20%.

Revenue
47.48M
Revenue Growth
-84.27%
P/S Ratio
1.67
Revenue / Employee
1.44M
Employees
33
Market Cap
79.45M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202547.48M-254.35M-84.27%
Dec 31, 2024301.83M285.14M1,708.93%
Dec 31, 202316.69M9.81M142.69%
Dec 31, 20226.88M2.53M58.38%
Dec 31, 20214.34M4.03M1,284.88%
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Dec 31, 2011 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Vaxart237.26M
Nuo Therapeutics3.31M
Northwest Biotherapeutics1.38M
Harvard Apparatus Regenerative Technology704.00K
Silence Therapeutics559.00K
Zenith Capital500.00K
Provectus Biopharmaceuticals336.11K
Arch Biopartners115.29K
Revenue Rankings

BioStem Technologies News

More News